PATENT CLAIM ANALYSIS

Application Number: 16101027
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-06
Patent Classification: ["514", "043000"]

Abstract:
The present invention provides combination therapy methods of treating a proliferative disease (such as cancer) comprising a first therapy comprising administering to an individual an effective amount of a taxane in a nanoparticle composition, and a second therapy which may include the administration of an effective amount of at least one other agent that modifies the epigenetics in a cell.

Claim (Index 8):
The method according to  claim 1 , wherein the proliferative disease is cancer.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 96.0
- Lexical Diversity: 1.3617
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14631671', '13779624', '13779625', '12436697', '12519126']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8137183622071211
- 35 USC 102 Novelty (BERT): 0.5444112159671911
- Combined Prediction Score: 0.7867876475831281
- Mean Citation Score: 394.975836
- Max Citation Score: 402.2938
- Similarity Product: 303.6048505056739

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test